LSR antibody promotes apoptosis and disrupts epithelial barriers via signal pathways in endometrial cancer

References

• Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of icidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):247–264. doi:10.3322/caac.21492.
   Web of Science ®Google Scholar
• Katanoda K, Hori M, Matsuda T, Shibata A, Nishino Y, Hattori M, Soda M, Ioka A, Sobue T, Nishimoto H. An updated report on the trends in cancer incidence and mortality in Japan, 1958-2013. Jpn J Clin Oncol. 2015;45(4):390–401. doi:10.1093/jjco/hyv002.
   PubMed Web of Science ®Google Scholar
• Madeddu C, Sanna E, Gramignano G, Tanca L, Cherchi MC, Mola B, Petrillo M, Macciò A. Correlation of Leptin, Proinflammatory cytokines and oxidative stress with tumor size and disease stage of endometrioid (type I) endometrial cancer and review of the underlying mechanisms. Cancers (Basel). 2022;14(2):268. doi:10.3390/cancers14020268.
   PubMed Web of Science ®Google Scholar
• Matter K, Balda MS. Signalling to and from tight junctions. Nat Rev Mol Cell Biol. 2003;4(3):225–237. doi:10.1038/nrm1055.
   PubMed Web of Science ®Google Scholar
• Balda MS, Matter K. Tight junctions and the regulation of gene expression. Biochim Biophys Acta. 2009;1788:761–767. doi:10.1016/j.bbamem.2008.11.024.
   PubMed Web of Science ®Google Scholar
• Li J. Targeting claudins in cancer: diagnosis, prognosis and therapy. Am J Cancer Res. 2021;11(7):3406–3424. PMID: 34354852.
   PubMed Web of Science ®Google Scholar
• Ikari A, Sato T, Watanabe R, Yamazaki Y, Sugatani J. Increase in claudin-2 expression by an EGFR/MEK/ERK/c-Fos pathway in lung adenocarcinoma A549 cells. Biochim Biophys Acta. 2012;1823(6):1110–1118. doi:10.1016/j.bbamcr.2012.04.005.
   PubMed Web of Science ®Google Scholar
• Kinugasa T, Huo Q, Higashi D, Shibaguchi H, Kuroki M, Tanaka T, Futami K, Yamashita Y, Hachimine K, Maekawa S, et al. Selective up-regulation of claudin-1 and claudin-2 in colorectal cancer. Anticancer Res. 2007;27(6A):3729–3734. PMID: 17970035.
   PubMed Web of Science ®Google Scholar
• Xin S, Huixin C, Benchang S, Aiping B, Jinhui W, Xiaoyan L, Yu WB, Minhu C. Expression of Cdx2 and claudin-2 in the multistage tissue of gastric carcinogenesis. Oncology. 2007;73(5–6):357–365. doi:10.1159/000135351.
   PubMed Web of Science ®Google Scholar
• Okada T, Konno T, Kohno T, Shimada H, Saito K, Satohisa S, Saito T, Kojima T. Possibility of targeting claudin-2 in therapy for human endometrioid endometrial carcinoma. Reprod Sci. 2020;27(11):2092–2103. doi:10.1007/s43032-020-00230-6.
   PubMed Web of Science ®Google Scholar
• Pan XY, Li X, Che YC, Li HY, Li X, Zhang Y, Yang X. Ovrexpression of claudin-4 may be involved in endometrial tumorigenesis. Oncol Lett. 2013;5(4):1422–1426. doi:10.3892/ol.2013.1198.
   PubMed Web of Science ®Google Scholar
• Furuse M, Oda Y, Higashi T, Iwamoto N, Masuda S. Lipolysis-stimulated lipoprotein receptor: a novel membrane protein of tricellular tight junctions. Ann N Y Acad Sci. 2012;1257:54–58. doi:10.1111/j.1749-6632.2012.06486.x.
   PubMed Web of Science ®Google Scholar
• Masuda S, Oda Y, Sasaki H, Ikenouchi J, Higashi T, Akashi M, Nishi E, Furuse M. LSR defines cell corners for tricellular tight junction formation in epithelial cells. J Cell Sci. 2011;124(4):548–555. doi:10.1242/jcs.072058.
   PubMed Web of Science ®Google Scholar
• Kohno T, Konno T, Kojima T. Role of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor (LSR) in cancer cells. Int J Mol Sci. 2019;20(14):3555. doi:10.3390/ijms20143555.
   PubMed Web of Science ®Google Scholar
• Shimada H, Satohisa S, Kohno T, Takahashi S, Hatakeyama T, Konno T, Tsujiwaki M, Saito T, Kojima T. The roles of tricellular tight junction protein lipolysis-stimulated lipoprotein receptor in malignancy of human endometrial cancer cells. Oncotarget. 2016;7(19):27735–27752. doi:10.18632/oncotarget.8408.
   PubMedGoogle Scholar
• Hiramatsu K, Serada S, Enomoto T, Takahashi Y, Nakagawa S, Nojima S, Morimoto A, Matsuzaki S, Yokoyama T, Takahashi T, et al. LSR antibody therapy inhibits ovarian epithelial tumor growth by inhibiting lipid uptake. Cancer Res. 2018;78(2):516–527. doi:10.1158/0008-5472.CAN-17-0910.
   PubMed Web of Science ®Google Scholar
• Sugase T, Takahashi T, Serada S, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, et al. Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer. Oncotarget. 2018;9(68):32917–32928. doi:10.18632/oncotarget.25952.
   PubMedGoogle Scholar
• Furuse M, Izumi Y, Oda Y, Higashi T, Iwamoto N. Molecular organization of tricellular tight junctions. Tissue Barriers. 2014;2:e28960. doi:10.4161/trisb.28960.
   PubMedGoogle Scholar
• Higashi T, Tokuda S, Kitajiri S, Masuda S, Nakamura H, Oda Y, Furuse M. Analysis of the ‘angulin’ proteins LSR, ILDR1 and ILDR2-tricellulin recruitment, epithelial barrier function and implication in deafness pathogenesis. J Cell Sci. 2013;126(4):966–977. doi:10.1242/jcs.116442.
   PubMed Web of Science ®Google Scholar
• Nagahama M, Yamaguchi A, Hagiyama T, Ohkubo N, Kobayashi K, Sakurai J. Binding and internalization of Clostridium perfringens iota-toxin in lipid rafts. Infect Immun. 2004;72(6):3267–3275. doi:10.1128/IAI.72.6.3267-3275.2004.
   PubMed Web of Science ®Google Scholar
• Krug SM, Hayaishi T, Iguchi D, Watari A, Takahashi A, Fromm M, Nagahama M, Takeda H, Okada Y, Sawasaki T, et al. Angubindin-1, a novel paracellular absorption enhancer acting at the tricellular tight junction. J Control Release. 2017;260:1–11. doi:10.1016/j.jconrel.2017.05.024.
   PubMed Web of Science ®Google Scholar
• Konno T, Kohno T, Kikuchi S, Shimada H, Satohisa S, Saito T, Kondoh M, Kojima T. Epithelial barrier dysfunction and cell migration induction via JNK/cofilin/actin by angubindin-1. Tissue Barriers. 2020;8(1):1695475. doi:10.1080/21688370.2019.1695475.
   PubMed Web of Science ®Google Scholar
• Weston CR, Davis RJ. The JNK signal transduction pathway. Curr Opin Cell Biol. 2007;19(2):142–149. doi:10.1016/j.ceb.2007.02.001.
   PubMed Web of Science ®Google Scholar
• Naydenov NG, Hopkins AM, Ivanov AI. c-Jun N-terminal kinase mediates disassembly of apical junctions in model intestinal epithelia. Cell Cycle. 2009;8(13):2110–2121. doi:10.4161/cc.8.13.8928.
   PubMed Web of Science ®Google Scholar
• You H, Lei P, Andreadis ST, Aiping B, Jinhui W, Xiaoyan L, Yu WB, Minhu C. JNK is a novel regulator of intercellular adhesion. Tissue Barriers. 2013;1(5):e26845. doi:10.4161/tisb.26845.
   PubMedGoogle Scholar
• Nakatsu D, Kano F, Taguchi Y, Sugawara T, Nishizono T, Nishikawa K, Oda Y, Furuse M, Murata M. JNK1/2-dependent phosphorylation of angulin-1/LSR is required for the exclusive localization of angulin-1/LSR and tricellulin at tricellular contacts in EpH4 epithelial sheet. Genes Cells. 2014;19(7):565–581. doi:10.1111/gtc.12158.
   PubMed Web of Science ®Google Scholar
• Konno T, Ninomiya T, Kohno T, Kikuchi S, Sawada N, Kojima T. c-Jun N-terminal kinase inhibitor SP600125 enhances barrier function and elongation of human pancreatic cancer cell line HPAC in a Ca-switch model. Histochem Cell Biol. 2015;143(5):471–479. doi:10.1007/s00418-014-1300-4.
   PubMed Web of Science ®Google Scholar
• Guo C, Zheng C, Martin-Padura I, Bian ZC, Guan JL. Differential stimulation of proline-rich tyrosine kinase 2 and mitogen-activated protein kinase by sphingosine 1-phosphate. Eur J Biochem. 1998;257(2):403–408. doi:10.1046/j.1432-1327.1998.2570403.x.
   PubMedGoogle Scholar
• Nakatsu D, Kano F, Shinozaki-Narikawa N, Murata M, Horowitz A. Pyk2-dependent phosphorylation of LSR enhances localization of LSR and tricellulin at tricellular tight junctions. PLoS One. 2019;14(10):e0223300. doi:10.1371/journal.pone.0223300.
   PubMed Web of Science ®Google Scholar
• Pavlova NN, Thompson CB. The emerging hallmarks of cancer metabolism. Cell Metab. 2016 Jan 12;23(1):27–47. doi:10.1016/j.cmet.2015.12.006.
   PubMed Web of Science ®Google Scholar
• Chelakkot C, Ghim J, Ryu SH. Mechanisms regulating intestinal barrier integrity and its pathological implications. Exp Mol Med. 2018;50(8):1–9. doi:10.1038/s12276-018-0126-x.
   PubMed Web of Science ®Google Scholar
• Shimada H, Kohno T, Konno T, Takahashi S, Hatakeyama T, Konno T, Tsujiwaki M, Saito T, Kojima T. The roles of tricellular tight junction protein Angulin-1/Lipolysis-Stimulated Lipoprotein Receptor (LSR) in endometriosis and endometrioid-endometrial carcinoma. Cancers (Basel). 2021;13(24):6341. doi:10.3390/cancers13246341.
   PubMed Web of Science ®Google Scholar
• Tsukita S, Yamazaki Y, Katsuno T, Fujimoto M, Ohkawara T, Hiramatsu K, Koh M, Saito Y, Tanaka K, Miyazaki Y, et al. Tight junction-based epithelial microenvironment and cell proliferation. Oncogene. 2088;27(55):6930–6938. doi:10.1038/onc.2008.344.
   Google Scholar
• Kyuno D, Takasawa A, Kikuchi S, Takemasa I, Osanai M, Kojima T. Role of tight junctions in the epithelial-to-mesenchymal transition of cancer cells. Biochim Biophys Acta Biomembr. 2021;1863(3):183503. doi:10.1016/j.bbamem.2020.183503.
   PubMed Web of Science ®Google Scholar
• Kolchakova D, Moten D, Batsalova T, Dzhambazov B. Tight junction protein claudin-12 is involved in cell migration during metastasis. Biomolecules. 2021;11(5):636. doi:10.3390/biom11050636.
   PubMed Web of Science ®Google Scholar
• Hashimoto Y, Tachibana K, Krug SM, Kunisawa J, Fromm M, Kondoh M. Potential for tight Junction protein-directed drug development using claudin binders and angubindin-1. Int J Mol Sci. 2019;20(16):4016. doi:10.3390/ijms20164016.
   PubMed Web of Science ®Google Scholar
• Nagase Y, Hiramatsu K, Funauchi M, Shiomi M, Masuda T, Kakuda M, Nakagawa S, Miyoshi A, Matsuzaki S, Kobayashi E, et al. Anti-lipolysis-stimulated lipoprotein receptor monoclonal antibody as a novel therapeutic agent for endometrial cancer. BMC Cancer. 2022;22:679. doi:10.1186/s12885-022-09789-6.
   PubMed Web of Science ®Google Scholar
• Benny S, Mishra R, Manojkumar MK, Aneesh TP. From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy. Med Hypotheses. 2020;144:110216. doi:10.1016/j.mehy.2020.110216.
   PubMed Web of Science ®Google Scholar
• Kodera Y, Chiba H, Konno T, Kohno T, Takahashi H, Kojima T. HMGB1-downregulated angulin-1/LSR induces epithelial barrier disruption via claudin-2 and cellular metabolism via AMPK in airway epithelial Calu-3 cells. Biochem Biophys Res Commun. 2020;527(2):553–560. doi:10.1016/j.bbrc.2020.04.113.
   PubMed Web of Science ®Google Scholar
• Kohno T, Kikuchi S, Ninomiya T, Kojima T. The bicellular tensile force sorts the localization of LSRs in bicellular and tricellular junctions. Ann N Y Acad Sci. 2017;1397(1):185–194. doi:10.1111/nyas.13362.
   PubMed Web of Science ®Google Scholar